KLTO: Total Utang marang Modal ANEW Medical, Inc.

Logo perusahaan publik Klotho Neurosciences Inc (KLTO)

The absence of commercial products and rising fundamental research costs make business scaling impossible for Klotho Neurosciences Inc (KLTO). Management, possessing a deep scientific background, focuses on combating neurodegeneration, while the indicator on the GURU.Markets platform market trend, visualized in monetary format, stands at 0.00. Klotho Neurosciences Inc (KLTO) is strengthening its authority in gerontology by creating unique therapy methods for age-related brain pathologies through the study of the Klotho protein.

KLTO - Total Utang marang Modal ANEW Medical, Inc. ing rentang 18.09.2024 - 11.03.2026

Rincian metrik lan analitis perusahaan Klotho Neurosciences (KLTO)

- rega lan prakiraan konsensus rega:
Bagan rega ANEW Medical|KLTO - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Klotho Neurosciences|KLTO - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Klotho Neurosciences|KLTO - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku anewmeds.com|KLTO - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Klotho Neurosciences Inc|KLTO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas ANEW Medical|KLTO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Klotho Neurosciences|KLTO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Klotho Neurosciences
Analisis dhasar perusahaan:KLTO, Klotho Neurosciences Inc
Barang utama ANEW Medical

This ratio measures the degree of the business's reliance on borrowed funds relative to its equity, allowing investors to assess financial stability and bankruptcy risks amid rising rates. By analyzing the total debt-to-equity ratio, one can filter out market noise and determine whether Klotho Neurosciences Inc (KLTO) possesses sufficient resources to develop gene therapies for Alzheimer's disease through strategic partnerships.

Pesaing wigati

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Utang marang Ekuitas Harmony Biosciences|Total Utang marang Modal biohavenpharma.com|Utang marang Ekuitas Amylyx Pharmaceuticals, Inc. (AMLX)|Utang marang Ekuitas TRVI (Trevi Therapeutics Inc)|Utang marang Ekuitas Praxis Medicines PRAX|Anavex Life Sciences Corp (AVXL) - Utang marang Modal|CBLL: Rasio Total Utang marang Ekuitas|Prothena Corporation PLC - Utang Agregat marang Modal|ALEC: Total Utang marang Modal|Annexon Biosciences - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Omeros Corp|Utang marang Modal Neurogene Therapeutics NGNE|Rasio Total Utang marang Ekuitas ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Neumora Therapeutics, Inc. NMRA|SCLX: Rasio Utang marang Ekuitas|Tevogen Bio Holdings, Inc. - Total Utang marang Modal|Utang marang Modal Alpha Cognition|CGTX (Cognition Therapeutics) - Rasio Total Utang marang Ekuitas|inhibikase.com (IKT) - Total Utang marang Modal|Utang marang Ekuitas Cassava Sciences|ASRT: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Coya Therapeutics, Inc. (COYA)|VTGN - Utang marang Modal|Utang marang Ekuitas Ovid Therapeutics OVID|Koefisien Total Utang marang Modal acumenpharm.com (ABOS)|CervoMed - Total Utang marang Modal|Alterity Therapeutics (ATHE) - Rasio Total Utang marang Ekuitas|CLNN: Total Utang marang Modal|PEPG - Koefisien Total Utang marang Modal|JUNS (Jupiter Neurosciences Inc) - Total Utang marang Modal|Utang marang Modal relmada.com RLMD|Utang marang Ekuitas Annovis Bio (ANVS)|gracetx.com - Rasio Utang marang Ekuitas|Total Utang marang Modal AIFF (Firefly Neuroscience Inc)|NRSN - Rasio Total Utang marang Ekuitas|Reviva Pharmaceuticals - Total Utang marang Modal|Utang marang Modal MetaVia Inc|NeurAxis (NRXS) - Utang marang Ekuitas|HSDT - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas PASG|NEUP: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal NERV|Koefisien Total Utang marang Modal athira.com|Utang marang Ekuitas Addex Therapeutics Ltd ADXN|ALZN: Rasio Utang marang Ekuitas|Cyclerion - Total Utang marang Modal|Protagenic Therapeutics (PTIX) - Rasio Total Utang marang Ekuitas|pasitheaclinics.com (KTTA) - Utang marang Ekuitas|Cortigent (CRGT) - Total Utang marang Modal|Utang marang Ekuitas Avenue Therapeutics, Inc.|Utang marang Ekuitas BCLI|Rasio Total Utang marang Ekuitas CARA (Cara Therapeutics, Inc)|Utang Agregat marang Modal CHRO|Utang marang Ekuitas Eliem Therapeutics Inc. ELYM|Intra-Cellular Therapies Inc. (ITCI) - Utang marang Modal|LBPH - Utang marang Ekuitas|MRNS (Marinus Pharmaceuticals Inc) - Rasio Utang marang Ekuitas|NKGN: Total Utang marang Modal|Utang marang Modal NeuroBo Pharma (NRBO)|Rasio Total Utang marang Ekuitas SAGE|Total Utang marang Modal synaptogen.com|Utang marang Ekuitas Trevena (TRVN)|VIGL (vigilneuro.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Anew Medical WENA|Cerevel Corp (CERE) - Utang marang Modal